- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03241758
Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy
August 4, 2017 updated by: Jesus Muñoz-Rodriguez, Corporacion Parc Tauli
Valuation Of Vascular Changes And Their Impact On Erectile Function By Penile Doppler Ultrasound And Analysis Of The Quality Of Life Of Patients Undergoing Laparoscopic Radical Prostatectomy
A study designed to evaluate vascular changes after radical laparoscopic prostatectomy using Doppler ultrasound and the impact of such changes on erectile function and quality of life of patients.
The baseline study will be compared with the study one year after surgery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
110
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Male patients with prostate cancer who underwent laparoscopic radical prostatectomy
Description
Inclusion Criteria:
- Male patients with prostate cancer who underwent laparoscopic radical prostatectomy
Exclusion Criteria:
- Patients who were not interested in their sexual function and refused to perform this study
- Patients who required adjuvant or salvage treatment for their prostate cancer (radiation therapy, chemotherapy or androgen deprivation therapy) during follow-up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group #1
Patients with prostate cancer who will undergo radical prostatectomy
|
Basal Doppler ultrasound and Doppler ultrasound one year after radical prostatectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Left and right Cavernous artery diameter
Time Frame: 1 year
|
mm
|
1 year
|
|
Left and right Systolic velocity cavernous artery
Time Frame: 1 year
|
cm/s
|
1 year
|
|
Left and right Diastolyc velocity cavernous artery
Time Frame: 1 year
|
cm/s
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jesus Muñoz-Rodriguez, MD, Corporacio Sanitaria Parc Tauli
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 29, 2011
Primary Completion (Actual)
August 2, 2017
Study Completion (Actual)
August 2, 2017
Study Registration Dates
First Submitted
August 3, 2017
First Submitted That Met QC Criteria
August 4, 2017
First Posted (Actual)
August 7, 2017
Study Record Updates
Last Update Posted (Actual)
August 7, 2017
Last Update Submitted That Met QC Criteria
August 4, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RadicalDoppler
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostatic Neoplasms
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
T.O.A.D. Oncology SARecruitingMetastatic Castration-Resistant Prostatic CancerAustralia, France, Canada, Spain, United States
-
Asan Medical CenterAstellas Pharma IncUnknownProstatic Neoplasms, ProstatectomyKorea, Republic of
Clinical Trials on Doppler ultrasound
-
The University of Texas Health Science Center,...University of Alabama at BirminghamCompleted
-
Ramsay Générale de Santémermoz hospitalRecruitingUpper Aero-intestinal Tract Cancer | Supraclavicular Flap | Anterior Thoracic Perforator ArteryFrance
-
Southeast University, ChinaQinghai UniversityRecruiting
-
Assiut UniversityNot yet recruitingUrinary Tract Injuries During Caesarean Section for Morbidly Adherent Placenta: Prospective and Retrospective StudyEgypt
-
Assiut UniversityUnknown
-
Central Hospital, Nancy, FranceUnknownCritically Ill | Central Venous Catheter Thrombosis | PARENTERAL NUTRITION | POST OPERATIVEFrance
-
Echosense Ltd.TerminatedSystemic Sclerosis | Pulmonary HypertensionIsrael
-
Echosense Ltd.TerminatedSystemic Sclerosis | Pulmonary HypertensionIsrael
-
Rambam Health Care CampusUnknownThrombosis of Portal Venous System.Israel
-
Centre Hospitalier le MansNot yet recruitingDoppler Ultrasound | Giant Cell Arteritis (GCA)France